Campbell & Co Investment Adviser’s Allergan plc AGN Stock Holding History

Campbell & Co Investment Adviser’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-3,901	Closed	-$577K	–	662
2018 Q4	$577K	Buy	+3,901	New	+$639K	0.57%	16
2018 Q3	–	Sell	-6,894	Closed	-$1.15M	–	579
2018 Q2	$1.15M	Buy	+6,894	New	+$1.11M	0.88%	5
2017 Q4	–	Sell	-1,085	Closed	-$222K	–	558
2017 Q3	$222K	Buy	1,085 +11	+1%	+$2.56K	0.18%	258
2017 Q2	$261K	Buy	+1,074	New	+$252K	0.24%	178
2015 Q2	–	Sell	-1,800	Closed	-$536K	–	270
2015 Q1	$536K	Buy	+1,800	New	+$513K	0.34%	111

Other funds holding AGN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Campbell & Co Investment Adviser's AGN Position: Q1 2019 in Review

Campbell & Co Investment Adviser sold out of Allergan plc (AGN) in Q1 2019, closing a stake of 3,901 shares — an estimated $577K sold.

Campbell & Co Investment Adviser first reported a position in AGN in Q1 2015 and held it in 5 quarters. The position peaked at $1.15M in Q2 2018. 991 funds tracked by Wall St. Rank hold AGN as of Q1 2019.

Campbell & Co Investment Adviser reported no remaining Allergan plc position as of Q1 2019 after selling out during the quarter.
Campbell & Co Investment Adviser sold 3,901 Allergan plc shares in Q1 2019, an estimated $577K.
Campbell & Co Investment Adviser first reported a position in Allergan plc in Q1 2015 and held it in 5 quarters.
Campbell & Co Investment Adviser's Allergan plc position peaked at $1.15M in Q2 2018.
991 funds tracked by Wall St. Rank held Allergan plc as of Q1 2019.

Based on Campbell & Co Investment Adviser's 13F filing for Q1 2019, filed 10 May 2019.